Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02014740

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
University of Miami (from the registry)
Registry
  • NCT NCT02014740
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02014740. Randomized; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2017-03 (actual). Results posted on 2018-03-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Condition
Overweight
Condition
Obesity
Intervention (Drug)
Liraglutide
Intervention (Drug)
Metformin
Lead sponsor
University of Miami (class: other)

Record details

Record id
cardio:ct-nct02014740
Content hash
8f6d6843e6be53c9a8d9dd810a72b0c8ed07e65c67630c371b016f7f4d696e53